A phenotype based approach for the immune monitoring of NY-ESO-1-specific CD4+ T cell responses in cancer patients

Clinical Immunology

Volumn 118, Issue 2-3, 2006, Pages 188-194

  Ayyoub, Maha ^a   Souleimanian, Naira E ^a   Godefroy, Emmanuelle ^a   Scotto, Luigi ^a   Hesdorffer, Charles S ^a   Old, Lloyd J ^a   Valmori, Danila ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

CD4+ T cells; Human; T cell epitopes; Tumor immunity

Indexed keywords

EPITOPE; NY ESO 1 ANTIGEN;

ANTIBODY DETECTION; ARTICLE; CANCER PATIENT; CD4+ T LYMPHOCYTE; CELL POPULATION; CELL SPECIFICITY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL;

ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; EPITOPES, T-LYMPHOCYTE; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOPHENOTYPING; MEMBRANE PROTEINS; MONITORING, IMMUNOLOGIC; NEOPLASMS;

EID: 32044435651     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2005.10.002     Document Type: Article

References (27)

1. P. van der Bruggen, C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma Science 254 1991 1643 1647
2. Y.T. Chen, M.J. Scanlan, U. Sahin, O. Tureci, A.O. Gure, S.L. Tsang, B. Williamson, E. Stockert, M. Pfreundschuh, and L.J. Old A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening Proc. Natl. Acad. Sci. U. S. A. 94 1997 1914 1918
3. M.J. Scanlan, A.O. Gure, A.A. Jungbluth, L.J. Old, and Y.T. Chen Cancer/testis antigens: an expanding family of targets for cancer immunotherapy Immunol. Rev. 188 2002 22 32
4. T. Nakada, Y. Noguchi, S. Satoh, T. Ono, T. Saika, T. Kurashige, S. Gnjatic, G. Ritter, Y.T. Chen, E. Stockert, Y. Nasu, T. Tsushima, H. Kumon, L.J. Old, and E. Nakayama NY-ESO-1 mRNA expression and immunogenicity in advanced prostate cancer Cancer Immun. 3 2003 10
5. K. Odunsi, A.A. Jungbluth, E. Stockert, F. Qian, S. Gnjatic, J. Tammela, M. Intengan, A. Beck, B. Keitz, D. Santiago, B. Williamson, M.J. Scanlan, G. Ritter, Y.T. Chen, D. Driscoll, A. Sood, S. Lele, and L.J. Old NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer Cancer Res. 63 2003 6076 6083
6. M. Ayyoub, R.N. Taub, M.L. Keohan, M. Hesdorffer, G. Metthez, L. Memeo, M. Mansukhani, H. Hibshoosh, C.S. Hesdorffer, and D. Valmori The frequent expression of cancer/testis antigens provides opportunities for immunotherapeutic targeting of sarcoma Cancer Immun. 4 2004 7
7. J.S. Goydos, M. Patel, and W. Shih NY-ESO-1 and CTp11 expression may correlate with stage of progression in melanoma J. Surg. Res. 98 2001 76 80
8. J. Konishi, S. Toyooka, M. Aoe, Y. Omura, K. Washio, K. Tsukuda, and N. Shimizu The relationship between NY-ESO-1 mRNA expression and clinicopathological features in non-small cell lung cancer Oncol. Rep. 11 2004 1063 1067
9. E. Jäger, Y.T. Chen, J.W. Drijfhout, J. Karbach, M. Ringhoffer, D. Jäger, M. Arand, H. Wada, Y. Noguchi, E. Stockert, L.J. Old, and A. Knuth Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes J. Exp. Med. 187 1998 265 270
10. E. Stockert, E. Jager, Y.T. Chen, M.J. Scanlan, I. Gout, J. Karbach, M. Arand, A. Knuth, and L.J. Old A survey of the humoral immune response of cancer patients to a panel of human tumor antigens J. Exp. Med. 187 1998 1349 1354
11. D. Valmori, N.E. Souleimanian, C.S. Hesdorffer, L.J. Old, and M. Ayyoub Quantitative and qualitative assessment of circulating NY-ESO-1 specific CD4+ T cells in cancer free individuals Clin. Immunol. 117 2005 161 167
12. Q. Chen, H. Jackson, P. Parente, T. Luke, M. Rizkalla, T.Y. Tai, H.C. Zhu, N.A. Mifsud, N. Dimopoulos, K.A. Masterman, W. Hopkins, H. Goldie, E. Maraskovsky, S. Green, L. Miloradovic, J. McCluskey, L.J. Old, I.D. Davis, J. Cebon, and W. Chen Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant Proc. Natl. Acad. Sci. U. S. A. 101 2004 9363 9368
13. I.D. Davis, W. Chen, H. Jackson, P. Parente, M. Shackleton, W. Hopkins, Q. Chen, N. Dimopoulos, T. Luke, R. Murphy, A.M. Scott, E. Maraskovsky, G. McArthur, D. MacGregor, S. Sturrock, T.Y. Tai, S. Green, A. Cuthbertson, D. Maher, L. Miloradovic, S.V. Mitchell, G. Ritter, A.A. Jungbluth, Y.T. Chen, S. Gnjatic, E.W. Hoffman, L.J. Old, and J.S. Cebon Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans Proc. Natl. Acad. Sci. U. S. A. 101 2004 10697 10702
14. D. Valmori, N.E. Souleimanian, C.S. Hesdorffer, G. Ritter, L.J. Old, and M. Ayyoub Identification of B cell epitopes recognized by antibodies specific for the tumor antigen NY-ESO-1 in cancer patients with spontaneous immune responses Clin. Immunol. 117 2005 24 30
15. M. Ayyoub, C.S. Hesdorffer, M. Montes, A. Merlo, D. Speiser, D. Rimoldi, J.C. Cerottini, G. Ritter, M. Scanlan, L.J. Old, and D. Valmori An immunodominant SSX-2-derived epitope recognized by CD4+ T cells in association with HLA-DR J. Clin. Invest. 113 2004 1225 1233
16. F. Haight Handbook of the Poisson Distribution 1967 Wiley New York
17. F. Sallusto, D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia Two subsets of memory T lymphocytes with distinct homing potentials and effector functions Nature 401 1999 708 712
18. A. Harari, F. Vallelian, and G. Pantaleo Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load Eur. J. Immunol. 34 2004 3525 3533
19. K.H. Lee, E. Wang, M.B. Nielsen, J. Wunderlich, S. Migueles, M. Connors, S.M. Steinberg, S.A. Rosenberg, and F.M. Marincola Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression J. Immunol. 163 1999 6292 6300
20. M. Marchand, N. van Baren, P. Weynants, V. Brichard, B. Dreno, M.H. Tessier, E. Rankin, G. Parmiani, F. Arienti, Y. Humblet, A. Bourlond, R. Vanwijck, D. Lienard, M. Beauduin, P.Y. Dietrich, V. Russo, J. Kerger, G. Masucci, E. Jager, J. De Greve, J. Atzpodien, F. Brasseur, P.G. Coulie, P. van der Bruggen, and T. Boon Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1 Int. J. Cancer 80 1999 219 230
21. V. Dutoit, R.N. Taub, K.P. Papadopoulos, S. Talbot, M.L. Keohan, M. Brehm, S. Gnjatic, P.E. Harris, B. Bisikirska, P. Guillaume, J.C. Cerottini, C.S. Hesdorffer, L.J. Old, and D. Valmori Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting J. Clin. Invest. 110 2002 1813 1822
22. T.B. Stuge, S.P. Holmes, S. Saharan, A. Tuettenberg, M. Roederer, J.S. Weber, and P.P. Lee Diversity and recognition efficiency of T cell responses to cancer PLoS Med. 1 2004 e28
23. G. Zeng, X. Wang, P.F. Robbins, S.A. Rosenberg, and R.F. Wang CD4(+) T cell recognition of MHC class II-restricted epitopes from NY-ESO-1 presented by a prevalent HLA DP4 allele: association with NY-ESO-1 antibody production Proc. Natl. Acad. Sci. U. S. A. 98 2001 3964 3969
24. H.M. Zarour, B. Maillere, V. Brusic, K. Coval, E. Williams, S. Pouvelle-Moratille, F. Castelli, S. Land, J. Bennouna, T. Logan, and J.M. Kirkwood NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells Cancer Res. 62 2002 213 218
25. S. Gnjatic, D. Atanackovic, E. Jager, M. Matsuo, A. Selvakumar, N.K. Altorki, R.G. Maki, B. Dupont, G. Ritter, Y.T. Chen, A. Knuth, and L.J. Old Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses Proc. Natl. Acad. Sci. U. S. A. 100 2003 8862 8867
26. K. Rezvani, M. Grube, J.M. Brenchley, G. Sconocchia, H. Fujiwara, D.A. Price, E. Gostick, K. Yamada, J. Melenhorst, R. Childs, N. Hensel, D.C. Douek, and A.J. Barrett Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation Blood 102 2003 2892 2900
27. D. Valmori, V. Dutoit, D. Liénard, D. Rimoldi, M. Pittet, P. Champagne, U. Ellefsen, U. Sahin, D. Speiser, F. Lejeune, J.-C. Cerottini, and P. Romero Naturally occurring HLA-A2 restricted CD8+ T cell response to the cancer testis antigen NY-ESO-1 in melanoma patients Cancer Res. 60 2000 4499 4506